Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NPM1c CAR-T cells |
| Trade Name | |
| Synonyms | BSB-2002|BSB 2002|BSB2002 |
| Drug Descriptions |
NPM1c CAR-T cells are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets HLA-A*02:01-binding NPM1 C-terminal mutations, which may lead to killing of NPM1-mutant tumor cells (PMID: 38516690, PMID: 30640174). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| NPM1c CAR-T cells | NPM1c CAR-T cells | 0 | 2 |